D'AMBROSIO, Lorenzo
 Distribuzione geografica
Continente #
NA - Nord America 2.267
EU - Europa 1.115
AS - Asia 777
SA - Sud America 69
AF - Africa 37
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 5
Totale 4.304
Nazione #
US - Stati Uniti d'America 2.174
IT - Italia 435
CN - Cina 334
FR - Francia 164
DE - Germania 106
JP - Giappone 95
GB - Regno Unito 90
IN - India 86
CA - Canada 77
ES - Italia 57
VN - Vietnam 47
SE - Svezia 43
BR - Brasile 31
PL - Polonia 31
AU - Australia 30
KR - Corea 29
PH - Filippine 29
TR - Turchia 27
NL - Olanda 26
BE - Belgio 21
TW - Taiwan 21
TH - Thailandia 20
HK - Hong Kong 17
EG - Egitto 15
IE - Irlanda 15
IL - Israele 15
CZ - Repubblica Ceca 13
MX - Messico 13
CH - Svizzera 12
CO - Colombia 11
RO - Romania 11
SG - Singapore 11
ZA - Sudafrica 11
CL - Cile 10
RU - Federazione Russa 10
UA - Ucraina 10
GR - Grecia 9
MK - Macedonia 9
FI - Finlandia 8
ID - Indonesia 8
PT - Portogallo 8
SA - Arabia Saudita 8
AR - Argentina 7
AT - Austria 7
IR - Iran 7
PE - Perù 7
HU - Ungheria 5
MY - Malesia 5
NO - Norvegia 5
CY - Cipro 4
HR - Croazia 4
KE - Kenya 4
LT - Lituania 4
NZ - Nuova Zelanda 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
CG - Congo 3
DK - Danimarca 3
IQ - Iraq 3
AP - ???statistics.table.value.countryCode.AP??? 2
EC - Ecuador 2
HN - Honduras 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
BD - Bangladesh 1
BF - Burkina Faso 1
BT - Bhutan 1
DZ - Algeria 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
PA - Panama 1
PK - Pakistan 1
SI - Slovenia 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.304
Città #
Fairfield 220
Houston 160
Ashburn 157
Woodbridge 140
Santa Cruz 128
Ann Arbor 95
Buffalo 95
Seattle 90
Cambridge 67
Wilmington 65
Beijing 52
Torino 47
Shanghai 45
Turin 44
Milan 40
Wuhan 38
Dong Ket 35
Fleming Island 33
Ottawa 25
Chicago 24
Rovello Porro 24
San Diego 24
Los Angeles 23
Stockholm 22
Warsaw 21
New York 20
Pisa 20
Rome 20
Boardman 18
Chengdu 16
Changsha 15
Las Vegas 13
Taipei 13
University Park 13
Dublin 12
San Jose 12
Seoul 12
Bangkok 11
Bengaluru 11
Toronto 11
Clearwater 10
Guangzhou 10
Hefei 10
Henderson 10
London 10
Dallas 9
Hangzhou 9
Muizenberg 9
Nanjing 9
Quezon City 9
Singapore 9
Tokyo 9
Bogotá 8
Changchun 8
Des Moines 8
Edinburgh 8
Mountain View 8
Philadelphia 8
Phoenix 8
San Francisco 8
Scranton 8
Barcelona 7
Brooklyn 7
Dearborn 7
Lake Forest 7
Madrid 7
Misilmeri 7
Pune 7
Shenyang 7
Sydney 7
Ankara 6
Atlanta 6
Bangalore 6
Esslingen 6
Gent 6
Harbin 6
Helsinki 6
Lima 6
Padova 6
Portland 6
Redmond 6
Settimo Torinese 6
Shinchiba 6
Tübingen 6
Absecon 5
Arezzo 5
Birmingham 5
Boulder 5
Cheyenne 5
Indianapolis 5
Istanbul 5
Jakarta 5
Mumbai 5
Naples 5
Paris 5
Pomezia 5
Prilep 5
Riva 5
Savona 5
Slough 5
Totale 2.343
Nome #
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial, file e27ce427-00c2-2581-e053-d805fe0acbaa 648
Complete Resolution of Life-Threatening Bleomycin-Induced Pneumonitis After Treatment With Imatinib Mesylate in a Patient With Hodgkin's Lymphoma: Hope for Severe Chemotherapy-Induced Toxicity?, file e27ce426-d991-2581-e053-d805fe0acbaa 534
Preventing Venous Thromboembolism in Patients with Cancer, file e27ce42e-544b-2581-e053-d805fe0acbaa 350
Anticoagulation for central venous catheters in patients with cancer., file e27ce427-0cf5-2581-e053-d805fe0acbaa 312
Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients, file e27ce42f-d4f3-2581-e053-d805fe0acbaa 310
Alpha-fetoprotein elevation in NUT midline carcinoma: a case report, file e27ce42b-2637-2581-e053-d805fe0acbaa 213
Post-Transplant Cyclophosphamide and Tacrolimus–Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors, file e27ce42d-231f-2581-e053-d805fe0acbaa 196
Next generation immune-checkpoints for cancer therapy, file e27ce42c-c704-2581-e053-d805fe0acbaa 194
PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models, file e27ce42b-7361-2581-e053-d805fe0acbaa 183
CD44v6 as innovative sarcoma target for CAR-redirected CIK cells, file e27ce42c-d51b-2581-e053-d805fe0acbaa 162
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy, file e27ce42d-a39a-2581-e053-d805fe0acbaa 157
Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways, file e27ce42d-e185-2581-e053-d805fe0acbaa 142
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group, file e27ce433-cdb4-2581-e053-d805fe0acbaa 125
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice, file e27ce42c-51f3-2581-e053-d805fe0acbaa 123
CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes, file e27ce430-b2f1-2581-e053-d805fe0acbaa 106
Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature., file e27ce426-f599-2581-e053-d805fe0acbaa 101
Pazopanib and trametinib as a synergistic strategy against osteosarcoma: Preclinical activity and molecular insights, file e27ce42f-e4dc-2581-e053-d805fe0acbaa 88
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors, file e27ce432-03f2-2581-e053-d805fe0acbaa 54
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series, file e27ce431-d217-2581-e053-d805fe0acbaa 47
Parp1 inhibitor and trabectedin combination does not increase tumor mutational burden in advanced sarcomas—a preclinical and translational study, file e27ce434-7d1c-2581-e053-d805fe0acbaa 45
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas., file e27ce426-fc4a-2581-e053-d805fe0acbaa 41
Targeting cyclin-dependent kinases in sarcoma treatment: Current perspectives and future directions, file fea43f8c-9636-491d-aea6-4eae604bc72c 41
Novel lymphocyte-independent antitumor activity by PD-1 blocking antibody against PD-1+ chemoresistant lung cancer cells, file 68f37efa-f34e-4e08-8b01-b1921586362f 34
Epha2 expression in bone sarcomas: Bioinformatic analyses and preclinical characterization in patient-derived models of osteosarcoma, ewing’s sarcoma and chondrosarcoma, file e27ce434-4a0c-2581-e053-d805fe0acbaa 33
Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients, file 6433b310-f77d-49a8-a81c-249f191ff898 31
How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience, file 64401377-71d4-451b-a5f9-44d3ae55e717 31
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group, file 15a6ef78-4c3e-41f0-8131-b8f923ddac58 29
New benchmarks to design clinical trials with advanced or metastatic liposarcoma or synovial sarcoma patients: An EORTC - Soft Tissue and Bone Sarcoma Group (STBSG) meta-analysis based on a literature review for soft-tissue sarcomas, file 5acb5141-a3a6-41ef-9c12-c474fea2b4cd 20
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination, file 2ffec199-1478-4bf3-9443-bc395c5485aa 15
Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib, file 88fcfde7-ac46-4545-aab7-4be2780afa9c 15
What Clinical Trials Are Needed for Treatment of Leiomyosarcoma?, file e27ce435-a359-2581-e053-d805fe0acbaa 15
Pancreaticoduodenectomy in the surgical management of primary retroperitoneal sarcoma, file c06924ff-b638-4f9b-a221-3081dafd3d46 10
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group, file e27ce42d-50ca-2581-e053-d805fe0acbaa 10
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST, file 69ddea7c-dc59-446c-bde7-e9bd7e699410 9
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world study, file 85ed5105-1746-45ce-86cc-6e1e9911aa18 9
Efficacy thresholds for clinical trials with advanced or metastatic leiomyosarcoma patients: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group meta-analysis based on a literature review for soft-tissue sarcomas, file 12e87d2e-1731-4874-b4c8-58eca312ef25 7
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study, file b9d03a50-c458-44ba-889b-d858e862ae48 5
Eribulin-based treatment in patients affected by sarcomas: a case series, file 24253a94-f523-4415-b0a9-599857ab6cb5 4
The Combination of Sorafenib and Everolimus abrogates mTORC-1 and mTORC2 up-regulation in preclinical models of Osteosarcoma., file 7c10a454-80d9-42d2-9372-32954969826e 4
Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group, file 933d1e8b-46d6-44a6-a498-c7c8f72fa729 4
Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial, file a6ed0a6e-b594-478e-9003-d44ef7b24811 4
A mutation-based radiomics signature predicts response to imatinib in Gastrointestinal Stromal Tumors (GIST), file 6999782a-890e-473f-84cb-5c6d3ba2cb19 3
Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumour, file e27ce42d-2e7c-2581-e053-d805fe0acbaa 3
DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study, file 4aa87035-7099-4539-902f-cb7131bc849a 2
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas., file e27ce426-fc49-2581-e053-d805fe0acbaa 2
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial, file e27ce427-00c3-2581-e053-d805fe0acbaa 2
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence: A Report From the Italian Sarcoma Group, file ea80f570-c2fe-472a-b85f-19c83365818c 2
Epigenetic determinants in soft tissue sarcomas: molecular mechanisms and therapeutic targets, file 40123cf0-ea09-4e27-a689-b71d040e9377 1
Reply to Deleterious effect of ifosfamide in leiomyosarcoma: Convergence of weak signals, file b703c467-0875-4bff-be44-92cbf259dcd6 1
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial, file e27ce432-4f99-2581-e053-d805fe0acbaa 1
Totale 4.478
Categoria #
all - tutte 6.959
article - articoli 0
book - libri 0
conference - conferenze 170
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.129


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019233 0 0 0 0 0 0 0 0 39 49 84 61
2019/2020815 56 53 32 88 52 42 60 96 88 107 77 64
2020/2021890 58 52 81 84 90 72 65 64 61 100 75 88
2021/2022941 91 80 59 100 92 41 61 48 84 53 176 56
2022/2023843 30 56 150 112 68 61 123 53 60 66 57 7
2023/2024352 14 28 39 51 50 23 78 54 15 0 0 0
Totale 4.478